Envoy Medical, Inc.
COCH
$0.68
$0.000.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 241.00K | 208.00K | 222.00K | 212.00K | 225.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 241.00K | 208.00K | 222.00K | 212.00K | 225.00K |
| Cost of Revenue | 684.00K | 820.00K | 804.00K | 815.00K | 742.00K |
| Gross Profit | -443.00K | -612.00K | -582.00K | -603.00K | -517.00K |
| SG&A Expenses | 9.15M | 9.42M | 8.66M | 8.31M | 8.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.32M | 20.64M | 19.92M | 19.69M | 19.48M |
| Operating Income | -22.08M | -20.43M | -19.70M | -19.48M | -19.26M |
| Income Before Tax | -23.76M | -21.79M | -21.27M | -19.52M | -20.80M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.76 | -21.79 | -21.27 | -19.52 | -20.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.76M | -21.79M | -21.27M | -19.52M | -20.80M |
| EBIT | -22.08M | -20.43M | -19.70M | -19.48M | -19.26M |
| EBITDA | -21.78M | -20.16M | -19.46M | -19.28M | -19.08M |
| EPS Basic | -1.24 | -1.37 | -1.41 | -1.37 | -1.49 |
| Normalized Basic EPS | -0.64 | -0.65 | -0.66 | -0.63 | -0.69 |
| EPS Diluted | -1.24 | -1.37 | -1.41 | -1.37 | -1.49 |
| Normalized Diluted EPS | -0.64 | -0.65 | -0.66 | -0.63 | -0.69 |
| Average Basic Shares Outstanding | 93.03M | 83.91M | 80.67M | 77.89M | 75.16M |
| Average Diluted Shares Outstanding | 93.03M | 83.91M | 80.67M | 77.89M | 75.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -7.66% | -11.17% | -20.06% | -18.75% | -11.77% |